Astrazeneca Sweden Investments Limited

POWER SEARCH PRICING

SOLUTIONS

astrazeneca sweden investments limited Company Information

Live

MatureDeclining

Company Number

04726837

Next Accounts

Sep 2025

Industry

Other business support service activities n.e.c.

Directors

Iain Collins

Jonathan Slade

View All

Shareholders

astrazeneca treasury limited

kudos pharmaceuticals limited

View All

Group Structure

View All

Contact

Registered Address

1 francis crick avenue, cambridge biomedical campus, cambridge, CB2 0AA

Website

www.astrazeneca.com

astrazeneca sweden investments limited Estimated Valuation

£45.8b

Pomanda estimates the enterprise value of ASTRAZENECA SWEDEN INVESTMENTS LIMITED at £45.8b based on Net Assets of £17.7b and 2.58x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Astrazeneca Sweden Investments Limited is a live company located in cambridge, CB2 0AA with a Companies House number of 04726837. It operates in the other business support service activities n.e.c. sector, SIC Code 82990. Founded in April 2003, it's largest shareholder is astrazeneca treasury limited with a 77.4% stake. Astrazeneca Sweden Investments Limited is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with declining growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Astrazeneca Sweden Investments Limited a 1 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 2 areas for improvement. Company Health Check FAQs

Health Rating1out of 5

1 Strong

0 Regular

2 Weak

Size

There is insufficient data available for this Key Performance Indicator!

Growth

3 year (CAGR) sales growth of -100%, show it is growing at a slower rate (6.4%)

EXPORT

Astrazeneca Sweden Investments Limited's latest turnover from December 2023 is 0 and the company has net assets of £17.7 billion. According to their latest financial statements, we estimate that Astrazeneca Sweden Investments Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009
Turnover	0	0	9,425,071	89,365,505	327,629,077	294,670,375	167,353,669	60,993,752	14,321,248	12,813,748	12,374,626	20,921,870	21,047,261	245,551,374	302,046,930
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	0	0	7,068,803	8,936,550	5,850,519	8,268,812	7,419,621	5,950,610	5,276,249	7,537,499	3,907,776	7,845,701	7,653,549	7,015,754	6,864,703
Gross Profit	0	0	2,356,268	80,428,954	321,778,558	286,401,564	159,934,048	55,043,142	9,044,999	5,276,249	8,466,849	13,076,169	13,393,711	238,535,621	295,182,227
Admin Expenses	0	0	12,164,096	53,150,797	-87,097,826	-8,096,889	-7,219,855	-9,597,554	-7,480,968	-7,291,374	-3,208,944	172,055	465,418	-3,198,205	4,935,306
Operating Profit	0	0	-9,807,828	27,278,157	408,876,384	294,498,453	167,153,903	64,640,696	16,525,967	12,567,623	11,675,793	12,904,114	12,928,293	241,733,826	290,246,921
Interest Payable	22,477,322	12,041,422	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Receivable	869,390,704	280,163,763	0	0	0	0	0	0	0	0	0	0	0	0	0
Pre-Tax Profit	846,913,382	268,122,341	2,356,268	80,428,954	321,778,558	286,401,564	159,934,048	55,043,142	9,044,999	5,276,249	8,466,849	13,076,169	13,393,711	238,535,621	295,182,227
Tax	48,968,451	5,619,330	-15,708,451	-60,931,026	6,581,834	-54,123,130	-32,976,092	-9,669,741	-1,507,500	-753,750	-1,953,888	-3,269,042	-3,826,775	-63,779,578	-85,496,755
Profit After Tax	895,881,834	273,741,671	-13,352,183	19,497,928	328,360,392	232,278,433	126,957,955	45,373,401	7,537,499	4,522,499	6,512,961	9,807,127	9,566,937	174,756,043	209,685,472
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	895,881,834	273,741,671	-13,352,183	19,497,928	328,360,392	232,278,433	126,957,955	45,373,401	7,537,499	4,522,499	6,512,961	9,807,127	9,566,937	174,756,043	209,685,472
Employee Costs	0	0	0	0	0	0	0	0	0	0	0	5,680,986	5,801,355	68,705,407	0
Number Of Employees	1	1	67	625	2,206	2,015	1,183	430	96	86	83	142	147	1,788	0
EBITDA*	0	0	-9,807,828	27,278,157	408,876,384	294,498,453	167,153,903	64,640,696	16,525,967	12,567,623	11,675,793	12,904,114	12,928,293	241,733,826	290,246,921

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009
Tangible Assets	0	0	0	0	0	0	0	0	0	0	98,997,004	0	0	0	0
Intangible Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments & Other	51,376,736	52,982,259	56,550,424	56,868,958	48,266,784	50,364,579	173,948,887	146,533,770	107,032,487	111,554,986	98,997,004	0	0	0	3,307,538,692
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	51,376,736	52,982,259	56,550,424	56,868,958	48,266,784	50,364,579	173,948,887	146,533,770	107,032,487	111,554,986	98,997,004	0	0	0	3,307,538,692
Stock & work in progress	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Debtors	0	0	0	0	0	0	0	0	0	0	12,962,094,568	0	0	0	0
Group Debtors	18,175,323,111	17,684,835,835	16,551,994,973	17,203,672,109	15,454,877,870	16,963,726,298	16,704,039,571	14,708,420,113	15,012,436,873	14,941,584,382	0	13,080,745,341	12,779,513,999	12,819,057,337	8,719,420,868
Misc Debtors	0	0	0	14,623,446	5,119,204	0	0	0	0	0	0	0	0	0	0
Cash	0	0	0	0	0	0	0	0	0	0	0	0	0	0	393,160,260
misc current assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total current assets	18,175,323,112	17,684,835,835	16,551,994,973	17,218,295,556	15,459,997,075	15,467,939,563	16,704,039,571	14,708,420,113	15,012,436,873	14,941,584,382	12,962,094,568	13,080,745,342	12,779,514,000	12,819,057,338	9,112,581,128
total assets	18,226,699,847	17,737,818,094	16,608,545,397	17,275,164,514	15,508,263,858	15,518,304,142	16,877,988,458	14,854,953,883	15,119,469,360	15,053,139,368	13,061,091,572	13,080,745,342	12,779,514,000	12,819,057,338	12,420,119,820
Bank overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	460,785,101	866,179,658	357,367,264	462,263,385	394,178,733	269,112,230	303,380,049	53,555,489	216,326,223	154,518,731	1	262,177,182	284,456,917	269,787,614	292,061,907
other short term finances	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	1,605,522	1,605,522	0	0	0	55,234,954	42,044,517	9,669,741	1,507,499	0	188,875,862	2,615,233	2,551,183	66,330,760	84,872,690
total current liabilities	462,390,624	867,785,181	357,367,264	462,263,385	394,178,733	319,476,810	345,424,567	63,225,231	217,833,723	154,518,731	188,875,863	264,792,416	287,008,100	336,118,375	376,934,598
loans	51,376,735	52,982,258	56,550,424	56,868,957	48,266,783	55,234,954	173,948,887	146,533,769	107,032,486	111,554,986	98,997,004	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	8,639,648	0	0	0	0	0	0	0	0	0	0	0	0
provisions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total long term liabilities	51,376,736	52,982,259	65,190,072	56,868,958	48,266,784	50,364,579	173,948,887	146,533,770	107,032,487	111,554,986	98,997,004	0	0	0	0
total liabilities	513,767,360	920,767,440	422,557,336	519,132,342	442,445,517	369,841,389	519,373,454	209,759,000	324,866,209	266,073,717	287,872,867	264,792,416	287,008,100	336,118,375	376,934,598
net assets	17,712,932,488	16,817,050,654	16,185,988,062	16,756,032,172	15,065,818,341	15,148,462,753	16,358,615,004	14,645,194,882	14,794,603,151	14,787,065,652	12,773,218,705	12,815,952,926	12,492,505,900	12,482,938,963	12,043,185,222
total shareholders funds	17,712,932,488	16,817,050,654	16,185,988,062	16,756,032,172	15,065,818,341	15,148,462,753	16,358,615,004	14,645,194,882	14,794,603,151	14,787,065,652	12,773,218,705	12,815,952,926	12,492,505,900	12,482,938,963	12,043,185,222

	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009
Operating Activities
Operating Profit	0	0	-9,807,828	27,278,157	408,876,384	294,498,453	167,153,903	64,640,696	16,525,967	12,567,623	11,675,793	12,904,114	12,928,293	241,733,826	290,246,921
Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Amortisation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Tax	48,968,451	5,619,330	-15,708,451	-60,931,026	6,581,834	-54,123,130	-32,976,092	-9,669,741	-1,507,500	-753,750	-1,953,888	-3,269,042	-3,826,775	-63,779,578	-85,496,755
Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Debtors	490,487,276	1,132,840,862	-666,300,583	1,758,298,482	-1,503,729,224	259,686,727	1,995,619,458	-304,016,760	70,852,491	1,979,489,814	-118,650,773	301,231,342	-39,543,338	4,099,636,469	8,719,420,868
Creditors	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	1,605,522	0	0	-55,234,954	13,190,437	32,374,776	8,162,242	1,507,499	-188,875,862	186,260,629	64,050	-63,779,577	-18,541,930	84,872,690
Deferred Taxes & Provisions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash flow from operations	-441,518,825	-1,125,616,010	640,784,304	-1,791,951,351	1,863,952,488	-6,120,967	-1,829,066,871	367,149,957	-54,326,525	-2,156,551,803	314,633,307	-291,532,220	-15,134,721	-3,940,224,151	-8,429,798,012
Investing Activities
capital expenditure	0	0	0	0	0	0	0	0	0	98,997,004	-98,997,004	0	0	0	0
Change in Investments	-1,605,523	-3,568,165	-318,534	8,602,174	-2,097,796	-123,584,308	27,415,117	39,501,283	-4,522,499	12,557,982	98,997,004	0	0	-3,307,538,692	3,307,538,692
cash flow from investments	1,605,523	3,568,165	318,534	-8,602,174	2,097,796	123,584,308	-27,415,117	-39,501,283	4,522,499	86,439,022	-197,994,008	0	0	3,307,538,692	-3,307,538,692
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	-405,394,557	508,812,394	-104,896,121	68,084,651	125,066,503	-34,267,819	249,824,560	-162,770,734	61,807,492	154,518,730	-262,177,181	-22,279,735	14,669,303	-22,274,293	292,061,907
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long term loans	-1,605,523	-3,568,166	-318,533	8,602,174	-6,968,171	-118,713,933	27,415,118	39,501,283	-4,522,500	12,557,982	98,997,004	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	-8,639,648	8,639,648	0	0	0	0	0	0	0	0	0	0	0	0
share issue	0	357,320,922	-556,691,927	1,670,715,902	-411,004,803	-1,442,430,684	1,586,462,167	-194,781,669	0	2,009,324,447	-49,247,182	313,639,899	0	264,997,698	11,833,499,750
interest	846,913,382	268,122,341	0	0	0	0	0	0	0	0	0	0	0	0	0
cash flow from financing	439,913,302	1,122,047,843	-653,266,933	1,747,402,727	-292,906,471	-1,595,412,436	1,863,701,845	-318,051,120	57,284,992	2,176,401,159	-212,427,359	291,360,164	14,669,303	242,723,405	12,125,561,657
cash and cash equivalents
cash	0	0	0	0	0	0	0	0	0	0	0	0	0	-393,160,260	393,160,260
overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
change in cash	0	0	0	0	0	0	0	0	0	0	0	0	0	-393,160,260	393,160,260

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for astrazeneca sweden investments limited. Get real-time insights into astrazeneca sweden investments limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for astrazeneca sweden investments limited by selecting its closest rivals, whether from the ADMINISTRATIVE AND SUPPORT SERVICE ACTIVITIES sector, other mature companies, companies in CB2 area or any other competitors across 12 key performance metrics.

ASTRAZENECA SWEDEN INVESTMENTS LIMITED group structure

Astrazeneca Sweden Investments Limited has no subsidiary companies.

Ultimate parent company

ASTRAZENECA PLC

02723534

ASTRAZENECA TREASURY LIMITED

02910116

2 parents

ASTRAZENECA SWEDEN INVESTMENTS LIMITED

04726837

ASTRAZENECA SWEDEN INVESTMENTS LIMITED Shareholders

astrazeneca treasury limited	77.43%
kudos pharmaceuticals limited	21.66%
astrazeneca uk limited	0.91%

Astrazeneca Sweden Investments Limited currently has 3 directors. The longest serving directors include Mr Iain Collins (May 2017) and Jonathan Slade (Jun 2018).

officer	country	age	start	end	role
Mr Iain Collins	United Kingdom	54 years	May 2017	-	Director
Jonathan Slade	United Kingdom	59 years	Jun 2018	-	Director
Ms Yvonne Bertlin	United Kingdom	60 years	Sep 2018	-	Director

P&L

December 2023

turnover

operating profit

gross margin

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

17.7b

+0.05%

total assets

18.2b

+0.03%

cash

net assets

Total assets minus all liabilities

Similar Companies

burbo extension ltd

4.5

clifford chance london limited

jimiki limited

4.5

fernhope limited

4.5

canon (uk) limited

3.5

company number

04726837

Type

Private limited with Share Capital

industry

82990 - Other business support service activities n.e.c.

incorporation date

April 2003

ultimate parent company

ASTRAZENECA PLC

previous names

astrazeneca sweden investments (June 2005)

address

1 francis crick avenue, cambridge biomedical campus, cambridge, CB2 0AA

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to astrazeneca sweden investments limited.

astrazeneca sweden investments limited Company Information

astrazeneca sweden investments limited Estimated Valuation

astrazeneca sweden investments limited Estimated Valuation

astrazeneca sweden investments limited Estimated Valuation

Astrazeneca Sweden Investments Limited Overview

Astrazeneca Sweden Investments Limited Health Check

ASTRAZENECA SWEDEN INVESTMENTS LIMITED financials

astrazeneca sweden investments limited Credit Report and Business Information

Astrazeneca Sweden Investments Limited Competitor Analysis

astrazeneca sweden investments limited Ownership

astrazeneca sweden investments limited directors

astrazeneca sweden investments limited company details

astrazeneca sweden investments limited Charges & Mortgages

astrazeneca sweden investments limited Companies House Filings - See Documents